0,966  0,002  CYP2C9 substrate
0,959  0,003  Cardiotonic
0,952  0,001  UGT1A6 substrate
0,948  0,003  CYP1A2 substrate
0,943  0,003  CYP2D6 substrate
0,939  0,005  Apoptosis agonist
0,931  0,004  Transcription factor NF kappa B inhibitor
0,926  0,003  CYP2C19 substrate
0,918  0,004  Antineoplastic (lung cancer)
0,914  0,001  UGT1A1 substrate
0,905  0,005  Antineoplastic (breast cancer)
0,884  0,005  CYP3A4 substrate
0,879  0,004  Antineoplastic (ovarian cancer)
0,870  0,005  Teratogen
0,867  0,005  Antineoplastic (colorectal cancer)
0,862  0,004  Heart failure treatment
0,859  0,003  NOS2 expression inhibitor
0,860  0,004  Prostate cancer treatment
0,856  0,005  Antineoplastic (colon cancer)
0,853  0,004  UDP-glucuronosyltransferase substrate
0,853  0,004  Respiratory analeptic
0,851  0,004  Analeptic
0,848  0,003  Antineoplastic (sarcoma)
0,847  0,006  Embryotoxic
0,831  0,004  Antineoplastic (cervical cancer)
0,830  0,004  Antineoplastic (glioma)
0,825  0,003  Diuretic
0,812  0,004  Antineoplastic (pancreatic cancer)
0,811  0,006  Carcinogenic
0,807  0,005  Chemopreventive
0,802  0,003  Hypoxia-inducible factor 1 alpha inhibitor
0,798  0,002  Anesthetic general
0,792  0,005  Antineoplastic (non-small cell lung cancer)
0,784  0,004  Proliferative diseases treatment
0,784  0,009  TNF expression inhibitor
0,762  0,003  UGT1A4 substrate
0,754  0,004  Antineoplastic (renal cancer)
0,753  0,005  Antineoplastic (melanoma)
0,733  0,010  Antileukemic
0,706  0,006  Cytotoxic
0,694  0,004  Anesthetic
0,689  0,004  Antineoplastic (glioblastoma multiforme)
0,711  0,029  Antiinflammatory
0,686  0,005  Antineoplastic (brain cancer)
0,679  0,004  Antineoplastic (liver cancer)
0,676  0,007  NOS3 expression inhibitor
0,647  0,013  Cholesterol antagonist
0,619  0,005  Antineoplastic (lymphoma)
0,608  0,005  Antineoplastic enhancer
0,610  0,010  Caspase 3 stimulant
0,602  0,004  UGT1A3 substrate
0,606  0,010  Hepatic disorders treatment
0,597  0,004  Transcription factor STAT3 inhibitor
0,581  0,004  Transcription factor STAT inhibitor
0,572  0,004  UGT2B4 substrate
0,571  0,003  UGT2B15 substrate
0,578  0,016  Immunosuppressant
0,564  0,007  Antineoplastic (carcinoma)
0,566  0,010  DNA damaging
0,569  0,014  UGT1A9 substrate
0,564  0,012  Nitric oxide antagonist
0,554  0,003  Androgen antagonist
0,550  0,000  Na+ K+ transporting ATPase inhibitor
0,552  0,004  Antidiarrheal
0,548  0,005  Antineoplastic (squamous cell carcinoma)
0,553  0,019  Antipruritic, allergic
0,533  0,005  Contraceptive
0,541  0,014  Antineoplastic (multiple myeloma)
0,523  0,003  Sodium/bile acid cotransporter inhibitor
0,520  0,004  UGT2B7 substrate
0,517  0,003  UGT2B9 substrate
0,531  0,017  CYP2C19 inhibitor
0,523  0,019  Cardioprotectant
0,524  0,021  Sensitization
0,495  0,004  Lipocortins synthesis antagonist
0,500  0,026  Antihypercholesterolemic
0,482  0,009  P-glycoprotein inhibitor
0,492  0,020  Cardiovascular analeptic
0,520  0,053  Caspase 9 stimulant
0,495  0,028  Bone diseases treatment
0,483  0,022  Cytostatic
0,461  0,004  Contraceptive male
0,450  0,003  ATPase inhibitor
0,462  0,024  Antihypertensive
0,451  0,015  Antineoplastic (endocrine cancer)
0,448  0,024  ICAM1 expression inhibitor
0,433  0,009  Prostate disorders treatment
0,425  0,011  Hepatoprotectant
0,430  0,037  Antifungal
0,423  0,034  AR expression inhibitor
0,412  0,023  Antiparasitic
0,461  0,074  Antineoplastic (solid tumors)
0,409  0,022  Antihypoxic
0,395  0,011  Antipruritic, non-allergic
0,395  0,012  Prostatic (benign) hyperplasia treatment
0,415  0,034  Antiosteoporotic
0,413  0,036  Lipoprotein disorders treatment
0,393  0,017  Antihelmintic
0,360  0,004  Choleretic
0,375  0,020  Abortion inducer
0,358  0,008  Neurotrophic factor enhancer
0,418  0,069  Antibacterial
0,391  0,041  Apoptosis antagonist
0,374  0,033  Mutagenic
0,347  0,007  UGT2B1 substrate
0,358  0,018  Antiviral (Herpes)
0,364  0,034  Cardiodepressant
0,336  0,008  Cholesterol synthesis inhibitor
0,337  0,010  Adenylate cyclase inhibitor
0,327  0,005  Farnesoid X receptor antagonist
0,345  0,030  Antineoplastic (lymphocytic leukemia)
0,313  0,004  UGT2B10 substrate
0,354  0,045  Antioxidant
0,346  0,045  Chemoprotective
0,325  0,024  Antiviral (Influenza)
0,317  0,018  Interferon gamma antagonist
0,324  0,042  Hypolipemic
0,306  0,042  Antimitotic
0,308  0,046  Angiogenesis stimulant
0,284  0,024  Antiacne
0,264  0,005  Hedgehog signaling inhibitor
0,279  0,023  Hair growth stimulant
0,273  0,020  Antiviral (Influenza A)
0,315  0,065  Spasmolytic
0,254  0,004  Antineoplastic alkaloid
0,256  0,007  Microtubule formation inhibitor
0,321  0,073  Immunostimulant
0,257  0,011  VEGF expression inhibitor
0,309  0,064  Antineoplastic (osteosarcoma)
0,249  0,004  Androgen agonist
0,239  0,004  Bile acid receptor antagonist
0,242  0,007  Aromatase inhibitor
0,242  0,008  Arachidonic acid antagonist
0,224  0,004  Progesterone antagonist
0,216  0,003  UGT2B11 substrate
0,209  0,003  Anabolic
0,211  0,008  Pregnane X receptor agonist
0,285  0,085  Interleukin 2 agonist
0,203  0,003  RNA-directed RNA polymerase stimulant
0,200  0,004  Glycine receptor antagonist
0,191  0,004  Anticholelithogenic
0,221  0,035  Protein kinase stimulant
0,217  0,032  Interleukin 6 antagonist
0,210  0,026  Protein-tyrosine phosphatase 1B inhibitor
0,207  0,025  Topoisomerase I inhibitor
0,189  0,010  ABCA1 expression enhancer
0,195  0,018  Growth stimulant
0,185  0,009  Estrogen agonist
0,202  0,031  Antifungal enhancer
0,171  0,005  Glycine receptor agonist
0,173  0,009  Estrogen receptor alpha antagonist
0,185  0,022  Liver cirrhosis treatment
0,177  0,019  Contraceptive female
0,201  0,043  Phospholipase C inhibitor
0,167  0,010  Postmenopausal disorders treatment
0,236  0,080  Antiprotozoal (Leishmania)
0,248  0,094  Radioprotector
0,261  0,107  CYP3A4 inhibitor
0,177  0,026  Endometrios treatment
0,207  0,056  Growth factor agonist
0,182  0,032  Antihyperlipoproteinemic
0,164  0,019  Estrogen antagonist
0,175  0,030  Adenylate cyclase stimulant
0,193  0,048  Toxic, respiratory center
0,167  0,023  Antineoplastic, alkylator
0,161  0,017  Actinic keratosis treatment
0,207  0,072  Antiarrhythmic
0,162  0,028  Antineoplastic antibiotic
0,186  0,053  Protein-tyrosine phosphatase inhibitor
0,148  0,016  SULT1E1 substrate
0,156  0,026  Sulfotransferase substrate
0,219  0,090  Vasodilator
0,133  0,005  H+/K+-transporting ATPase inhibitor
0,188  0,064  Growth hormone agonist
0,219  0,095  Antipyretic
0,127  0,004  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,140  0,019  Paget's disease treatment
0,217  0,098  DNA synthesis inhibitor
0,184  0,069  LDLR expression enhancer
0,121  0,009  Estrogen receptor beta agonist
0,117  0,006  Potassium channel Kv1.3 blocker
0,117  0,007  Estrogen receptor alpha agonist
0,145  0,036  Alcohol dehydrogenase substrate
0,178  0,070  Muscle relaxant
0,158  0,050  Psychosexual dysfunction treatment
0,153  0,048  DNA polymerase I inhibitor
0,127  0,022  Transcription factor NF kappa B stimulant
0,126  0,025  Lanosterol 14 alpha demethylase inhibitor
0,200  0,100  RNA-directed DNA polymerase inhibitor
0,102  0,005  Lipocortins synthesis agonist
0,173  0,079  Antirickettsial
0,123  0,029  Estrogen receptor beta antagonist
0,174  0,085  Wound healing agent
0,092  0,004  Farnesoid X receptor agonist
0,139  0,053  Antiviral (Hepatitis B)
0,096  0,011  SULT2A1 substrate
0,088  0,004  Glucose-6-phosphate dehydrogenase inhibitor
0,124  0,048  Expectorant
0,081  0,006  Glucocorticoid antagonist
0,165  0,091  Platelet adhesion inhibitor
0,085  0,012  5-Alpha-reductase inhibitor
0,152  0,079  Melanin inhibitor
0,077  0,005  Microtubule stabilization
0,080  0,011  Aldosterone antagonist
0,098  0,029  CDC25A inhibitor
0,135  0,067  Skin whitener
0,216  0,150  CTGF expression inhibitor
0,075  0,012  Liver X receptor agonist
0,077  0,015  Postcoital contraceptive
0,073  0,015  Acetyl-CoA transferase 2 inhibitor
0,122  0,066  Alkylator
0,098  0,043  ATPase (Vacuolar H+) inhibitor
0,137  0,084  Ca2+-transporting ATPase inhibitor
0,068  0,016  Anesthetic inhalation
0,227  0,176  Calcium channel activator
0,057  0,011  Hypogonadism treatment
0,161  0,116  Antihypertriglyceridemic
0,124  0,079  Antihemorrhagic
0,117  0,073  Carcinogenic, group 3
0,061  0,019  Mineralocorticoid receptor antagonist
0,152  0,111  Antineoplastic (bone cancer)
0,105  0,064  Antiinfertility, female
0,165  0,126  Antialcoholic
0,059  0,020  Estradiol 17 beta-dehydrogenase inhibitor
0,067  0,030  Heme oxygenase stimulant
0,041  0,004  Hedgehog signaling activator
0,053  0,017  Liver X receptor alpha agonist
0,045  0,010  Tubulin agonist
0,174  0,139  Peptidyltransferase inhibitor
0,047  0,013  Cholesterol absorption inhibitor
0,162  0,131  Free radical scavenger
0,168  0,136  VCAM1 expression inhibitor
0,051  0,020  Parathyroid hormone antagonist
0,079  0,050  Keratolytic
0,032  0,006  Corticosteroid-like
0,108  0,081  Autism spectrum disorders treatment
0,040  0,015  HMG CoA reductase inhibitor
0,085  0,061  Ornithine decarboxylase inhibitor
0,030  0,007  Progesterone agonist
0,170  0,148  Interleukin agonist
0,100  0,079  SULT1A1 substrate
0,074  0,055  SULT1A2 substrate
0,023  0,005  Vitamin D receptor agonist
0,026  0,007  Apical sodium codependent bile acid transporter inhibitor
0,198  0,180  Antithrombotic
0,027  0,010  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,023  0,007  Glucocorticoid agonist
0,122  0,106  Genotoxic
0,048  0,032  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,022  0,006  Telomerase stimulant
0,123  0,109  Eye irritation, high
0,115  0,103  Neurotrophic factor
0,024  0,012  Vitamin D receptor antagonist
0,050  0,040  Protein 50S ribosomal subunit inhibitor
0,010  0,002  Transcortin receptor antagonist
0,065  0,062  Antibiotic
0,025  0,022  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,092  0,091  Mucolytic
0,019  0,018  Estrone sulfatase inhibitor
0,064  0,063  Andropause treatment

